ClearPoint Neuro (CLPT) Interest Expenses (2011 - 2026)

ClearPoint Neuro's (CLPT) quarterly Interest Expenses came in at $1.4 million in Q1 2026, up 1418.68% quarter-over-quarter from $91000.0 in Q2 2022.

ClearPoint Neuro (CLPT) Interest Expenses (2011 - 2026) Analysis & Trends

ClearPoint Neuro has disclosed Interest Expenses across 12 years of filings, most recently posting $1.4 million for Q1 2026.

Interest Expenses for Q1 2026 came in at $1.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (changed N/A YoY), and the FY2025 annual result was $2.4 million, up 361.0% from the prior year.
Interest Expenses came in at $1.4 million for Q1 2026 at ClearPoint Neuro, up from $91000.0 in the prior quarter.
In the past five years, Interest Expenses ranged from a high of $1.4 million in Q1 2026 to a low of $91000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	174.00 Mn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	148.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	181.00 Mn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	90.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-97.17 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	96.00 Mn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	15.10 Mn
10	ClearPoint Neuro	524.46 Mn	488.86 Mn	7.76 Mn	1.38 Mn

Download Data